|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-10-26
|
|
pubmed:abstractText |
To evaluate the efficacy and toxicity of paclitaxel administered as a 1-hour infusion on weekly basis, without interruption, to patients with metastatic breast cancer who had received prior therapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AlbanellJJ,
pubmed-author:AlbanesDD,
pubmed-author:BaselgaJJ,
pubmed-author:CurrieVV,
pubmed-author:GollubMM,
pubmed-author:HudisC ACA,
pubmed-author:MoynahanM EME,
pubmed-author:NortonLL,
pubmed-author:SeidmanA DAD,
pubmed-author:TeplerII,
pubmed-author:TheodoulouMM,
pubmed-author:TongWW
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3353-61
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9779712-Adult,
pubmed-meshheading:9779712-Aged,
pubmed-meshheading:9779712-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9779712-Breast Neoplasms,
pubmed-meshheading:9779712-Drug Administration Schedule,
pubmed-meshheading:9779712-Female,
pubmed-meshheading:9779712-Humans,
pubmed-meshheading:9779712-Infusions, Intravenous,
pubmed-meshheading:9779712-Middle Aged,
pubmed-meshheading:9779712-Paclitaxel
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer.
|
|
pubmed:affiliation |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. seidman@mskcc.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Review,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
